Association of CD14 G(-1145)A and C(-159)T polymorphisms with reduced risk for tuberculosis in a chinese han population

Genetics and Molecular Research

Volumn 11, Issue 3, 2012, Pages 3425-3431

  Li, J C ^a   Zhang, Y C ^a   Zhang, X ^a   Zhao, M Y ^a   Xue, Y ^a,b   Zhao, Z Q ^b   Li, F J ^c   Wei, L L ^d   Sun, X J ^d   Wang, Y X ^e  

^a ZHEJIANG UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HANGZHOU RED CROSS HOSPITAL   (China)

^d The Sixth Hospital of Shaoxing   (China)

^e ZHEJIANG HOSPITAL   (China)

Author keywords

CD14; Chinese han; SNPs; Tuberculosis

Indexed keywords

ALANINE; CD14 ANTIGEN; CYSTEINE; GLYCINE; THREONINE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CD14 GENE; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IMMUNE RESPONSE GENE; IMMUNOREACTIVITY; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RISK; PROMOTER REGION; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS;

EID: 84930479342     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2012.September.25.11     Document Type: Article

References (24)

1. Davila S, Hibberd ML, Hari DR, Wong HE, et al. (2008). Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis. PLoS Genet. 4: e1000218.
2. Ding S, Li L and Zhu X (2008). Polymorphism of the interferon-gamma gene and risk of tuberculosis in a southeastern Chinese population. Hum. Immunol. 69: 129-133.
3. Ferwerda B, Kibiki GS, Netea MG, Dolmans WM, et al. (2007). The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS 21: 1375-1377.
4. Gu W, Dong H, Jiang DP, Zhou J, et al. (2008). Functional signifcance of CD14 promoter polymorphisms and their clinical relevance in a Chinese Han population. Crit. Care Med. 36: 2274-2280.
5. Härtel C, Rupp J, Hoegemann A, Bohler A, et al. (2008). 159C>T CD14 genotype - functional effects on innate immune responses in term neonates. Hum. Immunol. 69: 338-443.
6. Hoheisel G, Zheng L, Teschler H, Striz I, et al. (1995). Increased soluble CD14 levels in BAL fuid in pulmonary tuberculosis. Chest 108: 1614-1616.
7. Juffermans NP, Verbon A, van Deventer SJ, Buurman WA, et al. (1998). Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. J. Infect Dis. 178: 1839-1842.
8. Kang HJ, Choi YM, Chae SW, Woo JS, et al. (2006). Polymorphism of the CD14 gene in perennial allergic rhinitis. Int. J. Pediatr. Otorhinolaryngol. 70: 2081-2085.
9. Lawn SD, Labeta MO, Arias M, Acheampong JW, et al. (2000). Elevated serum concentrations of soluble CD14 in HIV- and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment. Clin. Exp. Immunol. 120: 483-487.
10. Liang XH, Cheung W, Heng CK, Liu JJ, et al. (2006). CD14 promoter polymorphisms have no functional signifcance and are not associated with atopic phenotypes. Pharmacogenet. Genomics 16: 229-236.
11. Liu CP, Li XG, Lou JT, Xue Y, et al. (2009). Association analysis of the PHOX2B gene with Hirschsprung disease in the Han Chinese population of Southeastern China. J. Pediatr. Surg. 44: 1805-1811.
12. Manaster C, Zheng W, Teuber M, Wachter S, et al. (2005). InSNP: a tool for automated detection and visualization of SNPs and InDels. Hum. Mutat. 26: 11-19.
13. Nejentsev S, Thye T, Szeszko JS, Stevens H, et al. (2008). Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations. Nat. Genet. 40: 261-262.
14. Rosas-Taraco AG, Revol A, Salinas-Carmona MC, Rendon A, et al. (2007). CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis. J. Infect Dis. 196: 1698-1706.
15. Rosman MD and Oner-Eyupoglu AF (1998). Clinical Presentation and Treatment of Tuberculosis. In: Fishman's Pulmonary Diseases and Disorders (Fishman AP, ed.). McGraw-Hill, New York, 2483-2502.
16. Rousseau F, Rehel R, Rouillard P, DeGranpre P, et al. (1994). High throughput and economical mutation detection and RFLP analysis using a minimethod for DNA preparation from whole blood and acrylamide gel electrophoresis. Hum. Mutat. 4: 51-54.
17. Shams H, Wizel B, Lakey DL, Samten B, et al. (2003). The CD14 receptor does not mediate entry of Mycobacterium tuberculosis into human mononuclear phagocytes. FEMS Immunol. Med. Microbiol. 36: 63-69.
18. Sugawara I, Yamada H, Li C, Mizuno S, et al. (2003). Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol. Immunol. 47: 327-336.
19. Sugawara I, Yamada H, Mizuno S, Takeda K, et al. (2003). Mycobacterial infection in MyD88-defcient mice. Microbiol. Immunol. 47: 841-847.
20. Triantaflou M and Triantaflou K (2002). Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 23: 301-304.
21. Ulevitch RJ and Tobias PS (1995). Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13: 437-457.
22. Vercelli D, Baldini M and Martinez F (2001). The monocyte/IgE connection: may polymorphisms in the CD14 gene teach us about IgE regulation? Int. Arch. Allergy Immunol. 124: 20-24.
23. Yim JJ, Lee HW, Lee HS, Kim YW, et al. (2006). The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans. Genes Immun. 7: 150-155.
24. Zhang G, Goldblatt J and LeSouef PN (2008). Does the relationship between IgE and the CD14 gene depend on ethnicity? Allergy 63: 1411-1417.